The 16 most recent market catalysts affecting $PG, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Sep 14, 2026
Geopolitical Risk
Bullish
Impact 92
Shares of consumer staples companies are trading higher as surging oil prices due to military strikes in Saudi Arabia, Yemen and the Strait of Hormuz helped push the U.S. 10-year yield to 5.00%. Investors may be seeking haven in stocks with better cash-generation profiles amid worries over elevated inflation and Fed interest rates.
The military strikes in key oil-producing regions are a significant geopolitical risk, directly impacting global oil supply and prices. This surge in oil prices fuels inflation con…
Sep 9, 2026
Macro/Central Bank
Bearish
Impact 85
Shares of consumer staples companies are trading lower as elevated energy prices increase the chances of a Fed rate hike in September, which may slow consumer demand, boost borrowing costs and crimp margins.
Elevated energy prices are a key inflation driver, increasing the likelihood of a September Fed rate hike. This would directly impact consumer staples companies by boosting their b…
Aug 7, 2026
Corporate Catalyst
Bearish
Impact 55
Argus Research Downgrades Procter & Gamble to Hold
Argus Research, through analyst Taylor Conrad, has downgraded Procter & Gamble (PG) from a 'Buy' to a 'Hold' rating. This change in recommendation signals a less optimistic view on…
Aug 4, 2026
Corporate Catalyst
Bullish
Impact 95
Procter & Gamble To Acquire Thorne From L Catterton's Flagship Fund; Deal Anticipated To Close Later In 2026
Procter & Gamble (PG) has announced its acquisition of Thorne, a leader in health and wellness solutions, from L Catterton's Flagship Fund. This move is significant as it represent…
Aug 4, 2026
Corporate Catalyst
Neutral
Impact 75
Procter & Gamble CEO, On CNBC, Says We'll Announce The Acquisition Of Thorne Today; To Buy For $3.8B
This acquisition is a significant corporate catalyst for both P&G and Thorne. For P&G, it represents a strategic expansion into the high-growth health and wellness supplement secto…
Jul 30, 2026
Corporate Catalyst
Bearish
Impact 55
HSBC Downgrades Procter & Gamble to Hold, Lowers Price Target to $149
HSBC has downgraded Procter & Gamble (PG) from a 'Buy' to a 'Hold' rating and lowered its price target from $182 to $149. This move indicates that HSBC analysts see less upside pot…
Jul 30, 2026
Corporate Catalyst
Bearish
Impact 55
Citigroup Maintains Buy on Procter & Gamble, Lowers Price Target to $170
Citigroup analyst Filippo Falorni maintained a 'Buy' rating on Procter & Gamble but lowered the price target from $181 to $170. This action signals that while the analyst still see…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 85
Procter & Gamble Reports Flat Organic Sales Amid Rising Costs
Procter & Gamble's Q4 earnings report revealed flat organic sales and a revenue figure that fell short of analyst expectations, despite a slight beat on adjusted EPS. The company's…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 85
Procter & Gamble shares are trading lower after the company reported worse-than-expected Q4 sales results and issued FY27 GAAP EPS guidance below estimates. Also, the company issued FY27 sales guidance below estimates.
The headline indicates a significant corporate catalyst for Procter & Gamble, with both current performance and future outlook falling short of expectations. This directly impacts …
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 55
Procter & Gamble Appoints President, CEO Shailesh Jejurikar To Additional Role Of Board Chairman, Effective Aug. 1, Succeeding Jon Moeller
This 8-K filing discloses a planned leadership transition at Procter & Gamble, with current President and CEO Shailesh Jejurikar adding the Chairman role in August 2026, succeeding…
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 85
Procter & Gamble Sees FY2027 Adj EPS $6.89-$7.11 vs $7.04 Est; Sees Sales $85.127B-$86.813B vs $89.412B Est
Procter & Gamble (PG) has released its financial outlook for fiscal year 2027, projecting adjusted EPS in the range of $6.89-$7.11 and sales between $85.127 billion and $86.813 bil…
Jul 29, 2026
Corporate Catalyst
Neutral
Impact 75
Procter & Gamble Sees FY2027 GAAP EPS $6.69-$6.95 vs $6.97 Est
Procter & Gamble (PG) has released its fiscal year 2027 GAAP EPS guidance, projecting a range of $6.69 to $6.95. This forecast falls below the current analyst consensus estimate of…
Jul 29, 2026
Corporate Catalyst
Bearish
Impact 92
Procter & Gamble Q4 Adj. EPS $1.43 Beats $1.41 Estimate, Sales $21.203B Miss $21.379B Estimate
Procter & Gamble (PG) released its Q4 earnings, showing a mixed performance. The company's adjusted EPS of $1.43 surpassed the analyst consensus of $1.41, which is a positive sign …
Jul 16, 2026
Corporate Catalyst
Bearish
Impact 55
JP Morgan Maintains Overweight on Procter & Gamble, Lowers Price Target to $162
JPMorgan analyst Andrea Teixeira maintained an 'Overweight' rating on Procter & Gamble (PG), signaling continued confidence in the company's long-term prospects. However, the price…
Jul 16, 2026
Market Technicals
Bullish
Impact 75
Shares of consumer staples companies are trading higher as investors rotate into defensive sectors amid recent market volatility and heightened uncertainty. Investors may be drawn to cash-generative, dividend-paying stocks as an inflation hedge.
The headline signals a significant shift in investor sentiment, moving away from growth or cyclical stocks towards more stable, defensive assets. This rotation is a direct response…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.